Eling W, Jerusalem C
Tropenmed Parasitol. 1977 Sep;28(3):293-301.
In the immunization procedure of Swiss and C3H/StZ mice against P. berghei the inoculum plays an important role. Only viable parasites are able to induce immunity when multiple inoculations (10(5) P.E. per mouse) or a single inoculation (1-4 X 10(7) P.E. per mouse) are administered. The inoculated parasitized erythrocytes should enter the vascular system. The subcutaneous route is inappropriate, since subsequent immune reactions are notably absent. In combination with a given suppressive regimen successful immunization depends on an optimum number of viable P.E. in the inoculum. All conditions that affect the proportion of viable parasites in the inoculum (route, storage, medium, temperature, donor) should be recognized and controlled. The actual immunizing capacity of the inoculum also depends on the magnitude and time of initiation of sulfathiazole treatment after inoculation. Suppressive treatment (300 mg/L) starting 2 days after inoculation was found optimal in order to render the procedure less sensitive to small differences in the number of P.E. inoculated. Conditions which lead to antimalarial immunity are apparently strain-specific.
在瑞士小鼠和C3H/StZ小鼠针对伯氏疟原虫的免疫程序中,接种物起着重要作用。当进行多次接种(每只小鼠10⁵个感染性疟原虫)或单次接种(每只小鼠1 - 4×10⁷个感染性疟原虫)时,只有活的寄生虫能够诱导免疫。接种的被寄生红细胞应进入血管系统。皮下途径不合适,因为随后明显没有免疫反应。与特定的抑制方案相结合,成功的免疫取决于接种物中活的感染性疟原虫的最佳数量。所有影响接种物中活寄生虫比例的条件(途径、储存、培养基、温度、供体)都应予以识别和控制。接种物的实际免疫能力还取决于接种后磺胺噻唑治疗开始的剂量和时间。发现接种后2天开始进行抑制治疗(300mg/L)是最佳的,以便使该程序对接种的感染性疟原虫数量的微小差异不太敏感。导致抗疟免疫的条件显然具有菌株特异性。